Navigation Links
Shareholder Class Action Filed Against Medtronic, Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Date:12/14/2007

RADNOR, Pa., Dec. 14 /PRNewswire/ -- The following statement was issued today by the law firm of Schiffrin Barroway Topaz & Kessler, LLP:

Notice is hereby given that a class action lawsuit was filed in the United States District Court for the District of Minnesota on behalf of all purchasers of securities of Medtronic, Inc. (NYSE: MDT) ("Medtronic" or the "Company") from June 25, 2007 through October 15, 2007, inclusive (the "Class Period").

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Schiffrin Barroway Topaz & Kessler, LLP (Darren J. Check, Esq. or Richard A. Maniskas, Esq.) toll free at 1-888-299-7706 or 1-610-667-7706, or via e-mail at info@sbtklaw.com.

The Complaint charges Medtronic and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Medtronic is engaged in the medical technology business. More specifically, the Complaint alleges that the Company failed to disclose and misrepresented the following material adverse facts which were known to defendants or recklessly disregarded by them: (1) that the Company had received a substantial and increased number of reports of death and serious injuries caused by fractures in its Sprint Fidelis defibrillator leads; (2) that the Company had failed to suspend distribution of its Sprint Fidelis defibrillator leads in the face of such mounting safety concerns; (3) that the Company, as such safety concerns were revealed, would be forced to suspend distribution of its Sprint Fidelis defibrillator leads; (4) that the FDA would consider this "removal action" to be a "medical device recall"; (
'/>"/>

SOURCE Schiffrin Barroway Topaz & Kessler, LLP
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
3. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
4. United Medicorp, Inc.s Shareholders Approve All Proposals
5. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
6. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
7. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
8. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
9. Flextronics Shareholders and Solectron Stockholders Approve Acquisition
10. Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction
11. NOVT Corporations Board of Directors Terminates Shareholder Rights Plan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...-- Davis Bregman , a pain management physician ... Manhattan in New York City. Patients will be abl...e at 212-918-1629 or sending an email from davis...ee the doctor in the less stressful home setting c... most patients. The service will be fee for servi...
(Date:11/8/2009)...-USNewswire/ -- Jon O,Brien, president of Catholic... the passage of HR 3962: ,, "Behavior in recen...ut core values. We in the prochoice community stay...e struggles ordinary Americans have making ends me...asic healthcare or have to choose between maintain...
(Date:11/8/2009)...y of Health holds open house at Victoria campus ,...mber 8, 2009 -- UCW Academy of Health invites anyo...squo;s health care industry to attend their open h..., ,UCW Academy of Health, which offers diplomas i... services, designs its programs to meet the needs ...
(Date:11/8/2009)...alled "Preventing and Healing AIDS Through Ou...s that AIDS is a result of multiple, repeated and ...system stressor agents, which can be either chemic...al. , Oakland, CA (PRWEB... cell biologists, physicians, chemists and other s...
(Date:11/8/2009)...-USNewswire/ -- Today, the House of Representative...ith, Ellsworth and Lipinski amendment to the "Affo...he amendment maintains the current policy of preve...s packages that include abortion. It clarifies tha...y credits and those who do not, can with their own...
Breaking Medicine News(10 mins):Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2
..., Calif., July 25 Thoratec,Corporation (Nasdaq: ...irculatory support therapies to save, support and ...l report its operating results for the second,quar... activities to all interested parties at 1:30 p.m....
...ity offers patients consumers tips and encourages ...ty, HARRISBURG, Pa., July 25 The Pennsylvania,Pa...tient Safety Day" which,is a national effort to en...or illness., "We understand the important role th...
... of Marketing Exclusivity Begins -, CORONA, Calif...PI ), a leading specialty pharmaceutical,company, ...commercial,shipment of its Omeprazole Delayed-Rele...arketing exclusivity for being the,first to file a...
...enefit ALS Therapy Alliance to be presented at Fen...WOONSOCKET, R.I., July 25 CVS/pharmacy announced ...ng $4.4 million in just 21 days,through its annual...llion for ALS research. This year,s fundraiser too...
... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale...6) 939-6100. , Hicksville...
...ON-SALEM, N.C. Researchers at Wake Forest Univer...standing clinical belief that the hepatitis C viru...estore itself after HIV patients are treated with ... according to the Centers for Disease Control. Int...
Other Medicine News:Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3
(Date:11/6/2009)...Newswire-FirstCall/ -- Recession in domestic and i...r Allied Healthcare Products in the first quarter ..., Sales declines pushed Allied into a loss for th... $745,000, or negative 9 cents per share, compared...0, or 3 cents per share. ,, Sales fell about 2...
(Date:11/6/2009)...v. 6 DUSA Pharmaceutical...ompany that is developing and marketing Levulan(&#...s focused on patients with common skin conditions,...cutive Officer, will present a corporate overview ...n Tuesday, November 10, 2009 at 10:00 a.m. ET at t...
(Date:11/6/2009).... 6 Watson Pharmaceutica...ceutical company, announced today that Paul Bisaro...will provide an overview and update of the Company...hcare Conference on Wednesday, November 11, 2009 a...ntation will be webcast live and can be accessed o...
Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 1Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 2Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 3Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 4Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 1Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 2Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 3Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 4Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 5Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 6Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 7Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 8Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 9AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 1AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 2AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 3AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 4AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 5
...f Defense Interested in Copper,s Ability to Reduce...ve Indoor Air Quality, NEW YORK, Aug. 1 Congress...crobial effectiveness of copper, brass and bronze ...ation, announced CDA President,Andrew G. Kireta Sr...etals to kill deadly,pathogens on touch surfaces i...
...ss Continues to Decline; Strategic Business Unit R...or NicVAX Phase 2b Proof of Concept ... Nabi,Biopharmaceuticals (Nasdaq: NABI ) today a... company recorded a net loss from continuing,opera... quarter ended June,30, 2007, compared to $13.7 mi...
Other Medicine Technology:Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals 2Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals 3Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 2Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 3Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 4Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 5Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 6Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 7Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 8Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 9Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 10Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 11Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 12Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 13
Amo Phaco Prestige
Storz Phaco Premiere
CataRhex PRO
Odyssey Phacoemulsification System
Medicine Products: